Solos Endoscopy, Inc. Has Retained Services of Experienced MedicalMarketing Firm for a 2010 Campaign
Advertising Associates International hasforty-five years of experience in medical and healthcare marketing
BOSTON, Nov. 5 /PINKSHEETS/ --Solos Endoscopy, Inc. (Pink Sheets: SNDY- News)is pleased to announce that the Company has retained the services ofAdvertising Associates International to manage its 2010 marketing, promotionaland advertising campaign. They offer complete media research, planning,placement and ad tracking analysis. They have been highly regarded in themarketing field for forty-five years and have represented numerous companies asthey achieved their marketing goals.
The AAI team includesmarketing, creative and technical specialists as well as consultants drawn fromthe medical, engineering and dental professions; people with experience inbusiness development who have helped clients build partnerships to leveragetheir marketing and promotional budgets.
"We are pleased to beworking with AAI once again to assist Solos Endoscopy gaining broader worldwideexposure. I was impressed with the results we achieved last time, and have highexpectations for what our present marketing campaign will accomplish,"stated Bob Segersten, President of Solos Endoscopy, Inc.
For more information onAdvertising Associates International, visit: www.aai-agency.com
About Solos Endoscopy, Inc.:
Solos Endoscopy, Inc. is aHealthCare technology company whose mission is to develop and marketbreakthrough technology, applications, medical devices and proceduraltechniques for the screening, diagnosis, treatment and management of medicalconditions. Backed by technical support, Solos' sales team can help make theright buying decisions for the hospital, surgery center, or physician officewith its catalog of FDA Approved products. Additional information is availableon the Company's website at: www.solosendoscopy.com.
Safe Harbor: This releaseincludes forward-looking statements within the meaning of Section 27A of theSecurities Act of 1933 and Section 27E of the Securities Act of 1934.Statements contained in this release that are not historical facts may bedeemed to be forward-looking statements. Investors are cautioned thatforward-looking statements are inherently uncertain. Actual performance andresults may differ materially from that projected or suggested herein due tocertain risks and uncertainties including, without limitation, ability toobtain financing and regulatory and shareholder approval for anticipatedactions.
Contact:
Investor Relations
BigApple Consulting USA
1407-389-5900
Source: Solos Endoscopy, Inc.